Phillips Chimpeni
University of Liverpool(GB)Malawi-Liverpool-Wellcome Trust Clinical Research Programme(MW)
Publications by Year
Research Areas
Malaria Research and Control, Mosquito-borne diseases and control, Hemoglobinopathies and Related Disorders, Trypanosoma species research and implications, HIV/AIDS drug development and treatment
Most-Cited Works
- → Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment of Plasmodium falciparum Malaria(2002)535 cited
- → Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial(2004)107 cited
- → Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study(2004)94 cited
- → Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi(2009)78 cited
- → Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial(2002)67 cited
- → Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: Authors' reply(2004)3 cited
- The effect of compliance upon clinical effectiveness of chlorproguanil-dapsone (CD) and artemether-lumefantrine (AL) when compared to sulfadoxine-pyrimethamine (SP) for the treatment of uncomplicated falcipaum malaria in Malawi - a randomised controlled trial(2007)
- Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria [1] (multiple letters)(2004)
- The effect of compliance upon clinical effectiveness of chlorproguanil-dapsone (CD) and artemether-lumefantrine (AL) when compared to sulfadoxine-pyrimethamine (SP) for the treatment of uncomplicated falciparum malaria in Malawi - A randomised controlled trial(2007)